You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Position article and guidelines
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

 

Online download statistics by month:

Online download statistics by month: May 2020 to September 2025

AbstractFullPdf
May 2020860860451
Jun 2020779779346
Jul 2020644644218
Aug 2020304303161
Sep 2020320320130
Oct 2020323323120
Nov 2020309306114
Dec 2020309309105
Jan 2021445445129
Feb 2021483484144
Mar 2021451451152
Apr 2021482482181
May 2021362362152
Jun 2021300300144
Jul 2021341341124
Aug 2021322322135
Sep 2021355355144
Oct 2021372373165
Nov 2021381383169
Dec 2021281289121
Jan 2022515529125
Feb 2022421437121
Mar 2022294319189
Apr 2022241254128
May 2022262273140
Jun 2022294310123
Jul 2022244265135
Aug 2022232249163
Sep 2022246258163
Oct 2022268276150
Nov 2022284292121
Dec 202220120191
Jan 2023282287107
Feb 202325425893
Mar 202326626998
Apr 2023253265132
May 2023258262101
Jun 2023313314107
Jul 2023298301101
Aug 202331031073
Sep 2023358359103
Oct 2023459460127
Nov 2023604606133
Dec 2023315325137
Jan 2024248251133
Feb 2024251255138
Mar 2024312317273
Apr 2024332336197
May 2024262263156
Jun 2024306308179
Jul 2024332338124
Aug 2024317317195
Sep 2024316322697
Oct 2024372375243
Nov 2024363368183
Dec 2024428436142
Jan 2025351352170
Feb 2025439441150
Mar 2025354354188
Apr 2025385385189
May 2025257258142
Jun 2025154156106
Jul 2025330
Sep 2025110
Total21678219469971